These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 9832346

  • 1. D2-dopamine receptor occupancy measured by IBZM-SPECT in relation to extrapyramidal side effects.
    Broich K, Grünwald F, Kasper S, Klemm E, Biersack HJ, Möller HJ.
    Pharmacopsychiatry; 1998 Sep; 31(5):159-62. PubMed ID: 9832346
    [Abstract] [Full Text] [Related]

  • 2. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.
    Klemm E, Grünwald F, Kasper S, Menzel C, Broich K, Danos P, Reichmann K, Krappel C, Rieker O, Briele B, Hotze AL, Möller HJ, Biersack HJ.
    Am J Psychiatry; 1996 Feb; 153(2):183-90. PubMed ID: 8561197
    [Abstract] [Full Text] [Related]

  • 3. [123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects.
    Schlösser R, Schlegel S, Hiemke C, Nickel O, Bockisch A, Rao ML, Hahn K.
    Psychiatry Res; 1997 Sep 29; 75(2):103-14. PubMed ID: 9351492
    [Abstract] [Full Text] [Related]

  • 4. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.
    Dresel S, Tatsch K, Dähne I, Mager T, Scherer J, Hahn K.
    J Nucl Med; 1998 Jul 29; 39(7):1138-42. PubMed ID: 9669383
    [Abstract] [Full Text] [Related]

  • 5. IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol.
    Küfferle B, Tauscher J, Asenbaum S, Vesely C, Podreka I, Brücke T, Kasper S.
    Psychopharmacology (Berl); 1997 Oct 29; 133(4):323-8. PubMed ID: 9372530
    [Abstract] [Full Text] [Related]

  • 6. Sertindole and dopamine D2 receptor occupancy in comparison to risperidone, clozapine and haloperidol - a 123I-IBZM SPECT study.
    Kasper S, Tauscher J, Küfferle B, Barnas C, Hesselmann B, Asenbaum S, Podreka I, Brücke T.
    Psychopharmacology (Berl); 1998 Apr 29; 136(4):367-73. PubMed ID: 9600582
    [Abstract] [Full Text] [Related]

  • 7. D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study.
    Meisenzahl EM, Dresel S, Frodl T, Schmitt GJ, Preuss UW, Rossmüller B, Tatsch K, Mager T, Hahn K, Möller HJ.
    J Psychopharmacol; 2000 Apr 29; 14(4):364-70. PubMed ID: 11198054
    [Abstract] [Full Text] [Related]

  • 8. In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol.
    Tauscher J, Küfferle B, Asenbaum S, Fischer P, Pezawas L, Barnas C, Tauscher-Wisniewski S, Brücke T, Kasper S.
    Psychopharmacology (Berl); 1999 Jan 29; 141(2):175-81. PubMed ID: 9952042
    [Abstract] [Full Text] [Related]

  • 9. Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint.
    Bernardo M, Parellada E, Lomeña F, Catafau AM, Font M, Gómez JC, López-Carrero C, Gutiérrez F, Pavía J, Salamero M.
    Psychiatry Res; 2001 Aug 25; 107(2):87-97. PubMed ID: 11530275
    [Abstract] [Full Text] [Related]

  • 10. Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.
    Corripio I, Catafau AM, Perez V, Puigdemont D, Mena E, Aguilar Y, Carrió I, Alvarez E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan 25; 29(1):91-6. PubMed ID: 15610950
    [Abstract] [Full Text] [Related]

  • 11. Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol.
    Tauscher J, Küfferle B, Asenbaum S, Tauscher-Wisniewski S, Kasper S.
    Psychopharmacology (Berl); 2002 Jun 25; 162(1):42-9. PubMed ID: 12107616
    [Abstract] [Full Text] [Related]

  • 12. In vivo (123)I IBZM SPECT imaging of striatal dopamine 2 receptor occupancy in schizophrenic patients.
    Barnas C, Quiner S, Tauscher J, Hilger E, Willeit M, Küfferle B, Asenbaum S, Brücke T, Rao ML, Kasper S.
    Psychopharmacology (Berl); 2001 Sep 25; 157(3):236-42. PubMed ID: 11605078
    [Abstract] [Full Text] [Related]

  • 13. In vivo effects on striatal dopamine D2 receptor binding by the novel atypical antipsychotic drug sertindole--a 123I IBZM single photon emission tomography (SPET) study.
    Pilowsky LS, O'Connell P, Davies N, Busatto GF, Costa DC, Murray RM, Ell PJ, Kerwin RW.
    Psychopharmacology (Berl); 1997 Mar 25; 130(2):152-8. PubMed ID: 9106913
    [Abstract] [Full Text] [Related]

  • 14. The role of striatal dopamine D2 receptors in the occurrence of extrapyramidal side effects: iodine-123-iodobenzamide single photon emission computed tomography study.
    Corripio I, Ferreira A, Portella MJ, Pérez V, Escartí MJ, Del Valle Camacho M, Sauras RB, Alonso A, Grasa EM, Carrió I, Catafau AM, Alvarez E.
    Psychiatry Res; 2012 Jan 30; 201(1):73-7. PubMed ID: 22281201
    [Abstract] [Full Text] [Related]

  • 15. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects.
    Farde L, Nordström AL, Wiesel FA, Pauli S, Halldin C, Sedvall G.
    Arch Gen Psychiatry; 1992 Jul 30; 49(7):538-44. PubMed ID: 1352677
    [Abstract] [Full Text] [Related]

  • 16. Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients.
    Pickar D, Su TP, Weinberger DR, Coppola R, Malhotra AK, Knable MB, Lee KS, Gorey J, Bartko JJ, Breier A, Hsiao J.
    Am J Psychiatry; 1996 Dec 30; 153(12):1571-8. PubMed ID: 8942453
    [Abstract] [Full Text] [Related]

  • 17. Dopamine D2 receptor occupancy measured by single photon emission computed tomography with 123I-Iodobenzamide in chronic schizophrenia.
    Volk S, Maul FD, Hör G, Schreiner M, Weppner M, Holzmann T, Pflug B.
    Psychiatry Res; 1994 Jun 30; 55(2):111-8. PubMed ID: 10711799
    [Abstract] [Full Text] [Related]

  • 18. Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine.
    Kessler RM, Ansari MS, Riccardi P, Li R, Jayathilake K, Dawant B, Meltzer HY.
    Neuropsychopharmacology; 2006 Sep 30; 31(9):1991-2001. PubMed ID: 16738543
    [Abstract] [Full Text] [Related]

  • 19. Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study.
    Busatto GF, Pilowsky LS, Costa DC, Ell PJ, Verhoeff NP, Kerwin RW.
    Psychopharmacology (Berl); 1995 Jan 30; 117(1):55-61. PubMed ID: 7536945
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.